These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36721634)

  • 1. Emerging Prevalence and Clinical Features of
    Ma S; Gong Y; Luo X; Peng Y; Zhang C; Zhang X; Hu X; Tang P; Yuan Z; Luo G; Li H
    Infect Drug Resist; 2023; 16():531-543. PubMed ID: 36721634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
    Huang YC; Lin YT; Wang FD
    Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
    Huang YC; Wu PF; Lin YT; Wang FD
    J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological, clinical, and laboratory features of patients infected with
    Li Y; Liu T; Shi C; Wang B; Li T; Huang Y; Xu Y; Tang L
    Front Public Health; 2022; 10():964046. PubMed ID: 36225778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan.
    Lin JN; Lai CH; Yang CH; Huang YH
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30545016
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug resistant Elizabethkingia meningoseptica bacteremia - Experience from a level 1 trauma centre in India.
    Govindaswamy A; Bajpai V; Trikha V; Mittal S; Malhotra R; Mathur P
    Intractable Rare Dis Res; 2018 Aug; 7(3):172-176. PubMed ID: 30181936
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
    Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
    Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections.
    Jean SS; Lee WS; Chen FL; Ou TY; Hsueh PR
    J Hosp Infect; 2014 Apr; 86(4):244-9. PubMed ID: 24680187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes of critically ill patients with Elizabethkingia meningoseptica: an emerging pathogen.
    Umair A; Nasir N
    Acute Crit Care; 2021 Aug; 36(3):256-261. PubMed ID: 34311517
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Aldoghaim FS; Kaabia N; Alyami AM; Alqasim MA; Ahmed MA; Al Aidaroos A; Al Odayani A
    New Microbes New Infect; 2019 Nov; 32():100617. PubMed ID: 31763048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of outbreaks and cross-border dissemination of the emerging pathogen: a genomic survey of
    Hu S; Chen Y; Xu H; Chen J; Hu S; Meng X; Ni S; Xiao Y; Zheng B
    Microbiol Spectr; 2023 Dec; 11(6):e0160223. PubMed ID: 37815354
    [No Abstract]   [Full Text] [Related]  

  • 12. Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone.
    Chan JC; Chong CY; Thoon KC; Tee NWS; Maiwald M; Lam JCM; Bhattacharya R; Chandran S; Yung CF; Tan NWH
    J Med Microbiol; 2019 Aug; 68(8):1167-1172. PubMed ID: 31199227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: The first case series from India.
    Ghafur A; Vidyalakshmi PR; Priyadarshini K; Easow JM; Raj R; Raja T
    South Asian J Cancer; 2013 Oct; 2(4):211-5. PubMed ID: 24455635
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lin JN; Lai CH; Yang CH; Huang YH
    Microorganisms; 2019 Aug; 7(9):. PubMed ID: 31466280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
    Huang YC; Huang YW; Lin YT; Wang FD; Chan YJ; Yang TC
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1373-1380. PubMed ID: 28265817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial
    Balakrishnan NK; Ghani ARI; Hassan MH; Mukmin LA; Hassan WMNW
    Surg Neurol Int; 2022; 13():370. PubMed ID: 36128129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Infection with
    Arbune M; Fotea S; Nechita A; Stefanescu V
    J Crit Care Med (Targu Mures); 2018 Jul; 4(3):96-100. PubMed ID: 30582002
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sahu MK; Balasubramaniam U; C B; Singh SP; Talwar S
    Indian J Crit Care Med; 2019 Feb; 23(2):104-105. PubMed ID: 31086457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of antimicrobial resistance genes sul and dfrA12 in hospital environmental isolates of Elizabethkingia meningoseptica.
    Jiang X; Wang D; Wang Y; Yan H; Shi L; Zhou L
    World J Microbiol Biotechnol; 2012 Nov; 28(11):3097-102. PubMed ID: 22806748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Susceptibility of
    Comba IY; Schuetz AN; Misra A; Friedman DZP; Stevens R; Patel R; Lancaster ZD; Shah A
    J Clin Microbiol; 2022 Jun; 60(6):e0254121. PubMed ID: 35510517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.